Eric Grazzini is a Director of CMC with a robust background in pharmacology and extensive experience in project and team management. They have held roles at organizations such as Sandoz and Just - Evotec Biologics, where they currently lead biosimilar projects. With expertise in CNS/pain, neuro-inflammation, molecular endocrinology, and metabolism, Eric is known for delivering on multiple objectives and driving projects to clinical phases. They obtained a Ph.D. in pharmacology, biochemistry, and molecular biology from Montpellier II University, further enhancing their strategic vision and innovative approach within the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices